MTN 003D

February 13, 2014

An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial

Sponsors: Division of AIDS, US National Institute of Allergy and Infectious Diseases (NIAID)
US National Institutes of Health (NIH)

Protocol Summary: MTN 003D is a qualitative exploratory study examining the larger contextual issues and specific aspects of MTN 003 (VOICE) that positively and negatively affected participants’ actual and reported product use.

Years: 2012 – 2014

Investigator: Z.M. Chirenje, MD, FRCOG

Locations: Seke South and Zengeza CRSs

MTN

Completed Study

Publication:

van der Straten A, Montgomery ET, Musara P, et al. (2015) Disclosure of pharmacokinetic drug results to understand nonadherence. AIDS. 2015 Oct 23;29(16): 2161-71.

Musara P, Montgomery ET, Mgodi NM, et al. How Presentation of Drug Detection Results Changed Reports of Product Adherence in South Africa, Uganda, and Zimbabwe. AIDS Behav. 2017 Jan 21.